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Geraniol is a commercially important terpene alcohol occurring in the essential oils of several aromatic plants. It is one of the most important
molecules in the flavour and fragrance industries and is a common ingredient in consumer products produced by these industries. In addition to its
pleasant odour, geraniol is known to exhibit insecticidal and repellent properties and used as a natural pest control agent exhibiting low toxicity.
Geraniol has been suggested to represent a new class of chemoprevention agents for cancer. Other biological activities such as antimicrobial, anti-
oxidant, anti-inflammatory and some vascular effects have also been investigated. The effect of geraniol as a penetration enhancer for transdermal
drug delivery has also attracted the attention of researchers and formulation scientists. This review aims to coherently discuss some of the most
important applications of geraniol and unites the results obtained from several studies reporting the biological properties of this molecule.
© 2010 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Bioactivity; Biosynthesis; Geraniol; Nerol; Repellency1. Introduction
Geraniol (3,7-dimethylocta-trans-2,6-dien-1-ol) is an acyclic
monoterpene alcohol with the chemical formula C10H18O. The
product referred to as “geraniol” is a mixture of the two cis-trans
isomers (Fig. 1) properly named geraniol (trans) and nerol (cis).
Geraniol was isolated from Palmarosa oil while nerol was
obtained from the oil of neroli (Bedoukian, 1986; Clark, 1998). It
is a common constituent of several essential oils and occurs in
Monarda fistulosa (N95%) (Simon et al., 1986), ninde oil (66.0%)
(Başer et al., 2005), rose oil (44.4%) (Baydar and Baydar, 2005),
palmarosa oil (53.5%) (Dubey and Luthra, 2001) and citronella
oil (24.8%) (Rajeswara Rao et al., 2004). Geraniol appears as a
clear to pale-yellow oil which is insoluble in water, but soluble in
most organic solvents. It is emitted from the flowers of many
species and it is present in vegetative tissues of many herbs and
often co-exists with geranial and neral, which are the oxidation
products of geraniol (Regev and Cone, 1976). Pharate females
(Tetranychus urticae) also emit geraniol (Regev and Cone, 1976).
Geraniol has characteristic rose-like odour and the taste
(at 10 ppm) is described as sweet floral rose-like, citrus with⁎ Corresponding author.
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doi:10.1016/j.sajb.2010.05.008fruity, waxy nuances (Burdock, 2010). This monoterpene al-
cohol is a widely used fragrance material. A survey of consumer
products revealed that it is present in 76% of investigated
deodorants on the European market, included in 41% of domestic
and household products and in 33% of cosmetic formulations
based on natural ingredients and its production exceeds
1000 metric tons per annum (Rastogi et al., 1996, 1998, 2001).
In addition, geraniol exhibits various biochemical and pharma-
cological properties. Researchers have shown geraniol to be an
effective plant-based insect repellent (Barnard and Xue, 2004)
and its potential as an antimicrobial agent has been highlighted in
several studies (e.g. Bard et al., 1988). Geraniol exerts in vitro and
in vivo antitumour activity against murine leukemia, hepatoma
and melanoma cells (Burke et al., 1997; Yu et al., 1995a,b).
The purpose of this paper is to provide an overview of the
published data on the biosynthesis and some of the biological
properties of geraniol.2. Biosynthesis and transformation
2.1. Biosynthesis of geraniol
Geraniol is known to be derived from geranyl diphosphate
(GPP) by related synthases based on a common ionization-ts reserved.
Fig. 1. Chemical structure of geraniol and nerol.
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is synthesized via head to tail condensation of isopentenyl
diphosphate (IPP) with dimethylallyl diphosphate (DMAPP).
IPP is in turn synthesized from cytoplasmic acetate-mevalo-
nate or the recently discovered plastidic non-mevalonate
(pyruvate/triose-phosphate) pathway (Mahmoud and Croteau,
2002). In general, geraniol biosynthesis is via the mevalonate
route, but in some plants geraniol is known to be synthesized
via the non-mevalonate pathway (Luan and Wüst, 2002).
Iijima et al. (2004) first purified and characterized geraniol
synthase (GES) from the peltate glands of sweet basil. This
geraniol synthase was highly specific and produced only
geraniol. Subsequently, Yang et al. (2005) reported the iso-
lation of cDNA clone functionally expressed in Escherichia
coli and identified as a geraniol synthase from Cinnamomum
tenuipilum.
The ratios of geraniol and geranyl acetate of lemongrass
(Cymbopogon flexuosus) fluctuated during leaf development.
The level of geranyl acetate decreased from ∼59 to ∼3%
whereas the level of geraniol increased from ∼33 to ∼91%
during the leaf growth period. These fluctuations clearly
indicated the role of an esterase involved in the conversion of
geranyl acetate to geraniol during leaf development (Fig. 2)
(Ganjewala and Luthra, 2009). These results are congruent with
a previous study by Dubey and Luthra (2001).
The biocatalytic production of high-value chemicals from
abundant, cheap and renewable feedstocks is an area of great
interest. The ability of the abundant triene β-myrcene from
hops to produce geraniol in the presence of the soil microbe,
Rhodococcus erythropolis was investigated by Thompson et al.
(2010). Pre-incubation of cells with the cytochrome P450
inhibitors metyrapone or 1-aminobenzotriazole reduced gera-
niol production by 23% and 73% respectively.Fig. 2. The transformation of geranyl acetate into geraniol according to Dubey
and Luthra (2001).2.2. Biotransformation of geraniol
In recent years there has been an increasing tendency to
produce aroma molecules from monoterpenes by biotechno-
logical conversion. Some research has focused on the adoption
of a plant cell or tissue culture process for the production of
various aroma compounds (Faria et al., 2009; Nunes et al.,
2009). Many micro-organisms have shown the ability to
metabolize geraniol into various derivatives (Demyttenaere
and De Pooter, 1996; Demyttenaere et al., 2000; Garcia Moruno
et al., 2002; Rama Devi and Bhattacharyya, 1978; Wood,
1969). Geraniol can be a starting material to prepare (R)-(+)-
citronellol in enantiomerically pure form by microbiological
(Saccharomyces cerevisiae) reduction (Gramatica et al., 1982).
Luan et al. (2005) also found that geraniol can be stereoselec-
tively reduced to (S)-citronellol, E/Z-isomerization to nerol,
oxidation to neral/geranial (Fig. 3) and glycosylation of the
corresponding monoterpene alcohols in grape mesocarp of Vitis
vinifera by in vivo-feeding experiments. Spores of Penicillium
digitatum were able to convert geraniol NAD+-dependently into
citral by citrol dehydrogenase. The citral formed was subse-
quently deacetylated by citral lyase to yield methylheptenone
(Wolken and Van Der Werf, 2001).
The biotransformation of geraniol by the common cutworm
(Spodoptera litura) larvae was investigated. Geraniol was
preferentially oxidized at the allylic methyl group and primary
alcohol by S. litura larvae and transformed to 8-hydroxyger-
aniol, 9-hydroxygeraniol, (2E,6E)-8-hydroxy-3,7-dimethyl-2,6-
octadienoic acid, (2E,6E)-3,7-dimethyl-2,6-octadiene-1,8-dioic
acid and (2E,6Z)-3,7-dimethyl-2,6-octadiene-1,9-dioic acid
(Takechi and Miyazawa, 2006).
3. Biological activities
3.1. Insecticide and repellent effects
Essential oils and their major components are emerging as
potential pest control agents due to their insecticidal, repellent
and/or antifeedant properties (Barnard and Xue, 2004; Papachris-
tos et al., 2004). Their low mammalian toxicity and biodegrad-
ability favour their development. Using an impregnated fabric
disc bioassay Jeon et al. (2009) studied the acaricidal activities
of geraniol from the oil of Pelargonium graveolens against the
storage food mite, Tyrophagus putrescentiae, and compared the
activity to the commercial acaricide, benzyl benzoate. The resultsFig. 3. The oxidation of geraniol to geranic acid according to Seubert and Fass
(1964).
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with the 50% lethal dose value being 1.95 μg/cm3 and 1.27 μg/
cm3, respectively. Another study showed that among four mono-
terpenes (α-pinene, geraniol, limonene and p-cymene), geraniol,
in a 5% dilution displayed the strongest acaricidal activity
againstOtodectes cynotis by direct contact with the mites (Traina
et al., 2005). Geraniol (1%) showed a reduction in the mean
number of ticks per animal of 98.4%, 97.3% and 91.3% at days 7,
14 and 21, respectively (Khallaayoune et al., 2009).
The mechanism of the insecticidal property ascribed to
geraniol was investigated by testing its neurophysiological effect
in Periplaneta americana (the American cockroach) and
Blaberus discoidalis (discoids). Geraniol suppressed spontaneous
and stimulus-evoked impulses recorded extracellularly in the
abdominal nerve cord, but increased spontaneous firing at lower
doses (threshold 2.5×10−4 M). Geraniol produced dose-related
biphasic effects on dorsal unpaired median neurons. Low doses
of geraniol (threshold ca. 10−4 M) reversibly increased the
frequency of spontaneous foregut contractions and abolished
these at 2×10−3 M (together with response to electrical
stimulation) (Price and Berry, 2006).
Mosquitoes pose a potential health risk, because they are
vectors of several serious diseases. Geraniol proved to be effective
in repelling mosquitoes (Omolo et al., 2004). Geraniol-based
products are available commercially in several countries as
natural repellents. Geraniol candles were found to be more
effective than citronella and linalool candles in protecting a
person from being bitten indoors by mosquitoes and sand flies
(Müller et al., 2008). In a comparative study between three
botanical natural repellents, a lemongrass extract in combination
with 25% geraniol oil exhibited the longest protection time
against mosquitoes (Qualls and Xue, 2009). Müller et al. (2009)
determined the degree of personal protection provided by
commercial citronella, linalool and geraniol candles or diffusers.
Indoors, the repellency rate of geraniol candles was 50%, while
the diffusers provided a repellency rate of 97%. Outdoors,
geraniol diffusers placed 6 m frommosquito traps repelled female
mosquitoes by 75%. Geraniol had significantly more repellent
activity than citronella or linalool in both indoor and outdoor
settings. Hao et al. (2008) evaluated the changes of the host-
seeking and blood-feeding behavior of Aedes albopictus
surviving in a space containing vapors of geraniol, eugenol,
citral, anisaldehyde, or citronellal by using an arm-in-cage test
and a bioassay of blood meals on a shaved mouse. After 48 h of
exposure to 0.250 μg/ml geraniol, almost 100%of themosquitoes
lost their host-seeking ability. Geraniol also significantly affected
the activation and orientation stages of the blood-feeding
behavior.
3.2. Anthelmintic activities
Human infection with parasites can cause zoonotic diseases
such as anisakiasis. Some monoterpenes have shown a
significant anti-helminthic activity in vitro and in vivo (Hierro
et al., 2006; Navarro et al., 2008). Leela et al. (1992)
investigated the nematicidal activity of essential oil of P.
graveolens and its major constituents (citronellol, geraniol andlinalool) against the root-knot nematode (Meloidogyne incog-
nita). Geraniol was found to be the most effective constituent.
Another study tested the anthelmintic activity of the essential oil
of Cymbopogon martinii (palmrosa) and its main constituent
geraniol in vitro employing the nematode, Caenorhabditis
elegans. The ED50 of geraniol was found to be 66.7 µg/ml,
suggesting geraniol as the putative anthelmintic principle of
palmrosa oil (Kumaran et al., 2003). Geraniol was also found to
exhibit larvicidal activity against the genus of roundworms
Contracaecum (Barros et al., 2009) and against marine
nematodes Anisakis simplex (Hierro et al., 2004).
3.3. Antimicrobial effects
Essential oils are known to exhibit antimicrobial activity
against a wide range of bacteria and fungi. The antimicrobial
activity of essential oils is due to their solubility in the phos-
pholipid bilayer of cell membranes (Knobloch et al., 1989). It was
also reported that the antibacterial activities of monoterpene
alcohols (including linalool, nerol, citronellol and geraniol) are
more effective than their antifungal activity (Suppakul et al.,
2003). Friedman et al. (2002) evaluated the bactericidal activity
levels of 96 essential oils and 23 oil compounds against
Campylobacter jejuni, E. coli, Listeria monocytogenes and
Salmonella enterica obtained from food and clinical sources by
using a microtiter plate assay. Geraniol was most active against E.
coli (with a bactericidal activity value of BA50 0.15), against L.
monocytogenes (BA50 0.28) and S. enterica (BA50 0.15). Among
the 66 essential oils/compounds tested, geraniol inhibited the
growth of both human and animal pathogens, Salmonella
typhimurium and E. coli (Si et al., 2006). According to Inouye
et al. (2001), geraniol in the gaseous state exhibited antibacterial
activity against respiratory tract pathogens, including Haemophi-
lus influenzae, Streptococcus pneumoniae, S. pyogenes and
Staphylococcus aureus. The in vitro antimicrobial activity of
geraniol towards seven strains of Erwinia amylovora, the causal
agent of ‘fire blight’ of rosaceous plants, was assessed in tube
cultures by Scortichini and Rossi (2008). All of the strains tested
at 1×105 cfu/ml were inhibited for 24 h by geraniol in the range
600–1500 µg/ml. Geraniol reduced the germ count by 64%when
vaporized with an air washer (Sato et al., 2007). The
antitubercular activity of citronellol, nerol and geraniol against
Mycobacterium tuberculosiswas evaluated in vitro and exhibited
MIC values between 64 and 128 µg/ml (Cantrell et al., 2001).
The antifungal action of palmarosa oil (Cymbopogon
martinii) is mainly attributed to its geraniol content (Prashar
et al., 2003). The antimicrobial action of palmarosa oil against
S. cerevisiae takes place via a two-step process. The first step
involves the passive entry of the oil into the plasma membrane
in order to initiate membrane disruption. The second stage was
the accumulation in the plasma membrane resulting in the
inhibition of cell growth. The antifungal activity can be ascribed
to the combined membrane effects such as increased bilayer
disorder and ion leakage. These effects disturbed the osmotic
balance of the cell through loss of ions, making its membrane
associated proteins inefficient due to increased membrane
disorder eventually leading to inhibition of cell growth or cell
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(2008). Essential oils are known to not only be active again in
the planktonic forms of microbes but also exert an inhibitory
effect on the more resistant biofilms. Among 10 tested terpenes,
carvacrol, geraniol and thymol were able to significantly reduce
biofilm development of a Candida albicans strain and induced
N80% inhibition of the biofilm when assayed at concentrations
of 0.06%. Therefore, carvacrol, geraniol and thymol can be
used as potential antibiofilm agents. Van Zyl et al. (2006)
tested 20 nature identical essential oil constituents for
antimalarial, antimicrobial and anti-oxidant properties. Geraniol
displayed strong activity against C. albicans (MIC value
19.5 mM). Palmarosa oil and geraniol were both found to
inhibit Cryptococcus neoformans, a fungus causing infection
during the last stages of AIDS (Viollon and Chaumont, 1994).
Geraniol exhibited significant antifungal activities toward
Colletorichum camelliae, with an MIC value of 440 μg/ml
(Zhang et al., 2006). When combined with vaginal washing,
geraniol (25 μg/ml) significantly decreased the viable cell
number of Candida albicans, and possibly offered protection
from vaginal inflammation (Maruyama et al., 2008).
Several plant extracts have exhibited synergistic activity
against micro-organisms. The essential oil of P. graveolens and
its main components (geraniol and citronellol) exhibited strong
synergism with ketoconazole against Trichophyton schoenleinii
and T. soudanense, with FIC indices in the range of 0.18–0.38
(Shin and Lim, 2004). In another combination study undertaken
by Rosato et al. (2007) on Norfloxacin and P. graveolens
essential oil, a synergistic effect was obtained against Bacillus
cereus, S. aureus and S. aureus 29213 with a FIC index of 0.50,
0.37 and 0.38, respectively. When Norfloxacin was adminis-
tered with geraniol, the antibacterial effects were also shown to
increase to a lesser extent. The essential oil of Helichrysum
italicum (2.5%) can significantly reduce the multidrug resis-
tance of Gram-negative bacteria, Enterobacter aerogenes, E.
coli, Pseudomonas aeruginosa, and Acinetobacter baumannii
to the antibiotic chloramphenicol. Combinations of this essen-
tial oil with phenylalanine arginine β-naphthylamide yielded
synergistic activity. Geraniol, an active constituent of H.
italicum, significantly increased the efficacy of β-lactams,
quinolones, and chloramphenicol by targeting efflux mecha-
nism (Lorenzi et al., 2009).
3.4. Anti-oxidant effects
Free radicals cause oxidation of biomolecules and ultimately
produce molecular alterations related to aging, arteriosclerosis,
cancer, Alzheimer's disease, diabetes and asthma (Edris, 2007).
Recently researchers have focused on essential oils as anti-
oxidants or free radical scavengers. Choi et al. (2000) investigated
34 citrus essential oils and their components for radical-
scavenging activities using the in vitro 1,1-diphenyl-2-picrylhy-
drazyl (DPPH) assay and comparing the activity with a standard
anti-oxidant, Trolox. Geraniol (a citrus volatile) showed marked
scavenging activities against the DPPH radical (87.7%, 235.9 mg
of Trolox equiv/ml). Tiwari and Kakkar (2009) also reported the
anti-oxidant potential of geraniol using tsigniertiary-butyl hydro-per-oxide stressed rat alveolar macrophages. Geraniol increased
the cell viability significantly and showed 45% increase
in superoxide dismutase activity, 120% increase in glutathione
content and restored the mitochondrial membrane potential.
Geraniol was found to significantly decrease lipid peroxidation,
inhibit NO release (64.61%) and ROS generation in the pre-
treated cells as compared to stressed cells. Geraniol also
showed significant protection against ROS. These results
indicated the pharmacological potential of geraniol in lung
inflammatory diseases where oxidative stress was a critical
control point.
3.5. Anticancer activities
Geraniol has demonstrated anticancer activity in vitro and in
vivo in a number of models of human cancer. It exhibited
chemotherapeutic activity towards pancreatic and other cancers
(Burke et al., 1997). Geraniol (100 μM) significantly inhibited
the anchorage-independent growth of human MIA PaCa2
pancreatic tumor cells, and Syrian Golden hamsters fed geraniol
at 20 g/kg diet exhibited complete inhibition of PC-1 pancreatic
tumour growth in vivo. Burke et al. (2002) further investigated
the mechanism of action of geraniol against pancreatic tumors.
They reported that geraniol can induce apoptosis and increase
expression of the proapoptotic protein Bak in cultured
pancreatic tumor cells. Wiseman et al. (2007) demonstrated
that geraniol caused arrest in the G0/G1 phase of the cell cycle
through induction of cyclin kinase inhibitors p21Cip1 and
p27Kip1, resulting in a reduction of Cdk2 activity and decreasing
expression of downstream cell cycle-related proteins in human
pancreatic adenocarcinoma cells. Geraniol showed chemopre-
ventive activities on hepatocarcinogenesis during the initial
phases of the RH model by inhibition of cell proliferation, DNA
damage and increasing hepatic placental glutathione S-trans-
ferase positive preneoplastic lesions (PNLs) apoptosis (Ong
et al., 2006). Yu et al. (1995b) also reported that female
Sprague–Dawley rats treated with geraniol for 2 weeks prior to
initiation with 7,12-dimethylbenz[α]anthracene and 22 weeks
afterwards presented inhibition of mammary tumour
multiplicity.
Geraniol has antiproliferative effects on hepatoma and
melanoma cell growth (Polo and De Bravo, 2006). The
antiproliferative effects of geraniol on human colon cancer
cells were related to its ability to reduce DNA synthesis leading
to a blockade of the cells in the S phase of the cell cycle
(Carnesecchi et al., 2001). 3-Hydroxy-3-methylglutaryl coen-
zyme A (HMG-CoA) reductase catalyzed the formation of
mevalonate, a precursor of cholesterol that was also required
for cell proliferation. Inhibition of mevalonate synthesis may be
a useful strategy to impair the growth of malignant
cells (Goldstein and Brown, 1990; Jakobisiak and Golab,
2003). Geraniol suppressed HMG-CoA reductase synthesis in
mammalian cells by decreasing the translation efficiency of
HMG-CoA reductase transcripts (Peffley and Gayen, 2003).
Pattanayak et al. (2009) found that geraniol can interact with
HMG-CoA reductase. Duncan et al. (2004) reported that
geraniol can inhibit proliferation, cell cycle progression, and
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independent of effects on HMG-CoA reductase activity. This
finding indicated that understanding the growth and cell cycle
inhibitory effects of plant isoprenoids would require further
investigation of mevalonate-independent mechanisms.
Geraniol (150 μM) has been identified to reduce thymidylate
synthase and thymidine kinase expression in colon cancer cells.
In nude mice, the combined administration of 5-fluorouracil
(20 mg/kg) and geraniol (150 mg/kg) caused a 53% reduction
of the tumor volume, whereas a 26% reduction was obtained
with geraniol alone (Carnesecchi et al., 2004). Mans et al.
(1999) found that thymidylate synthase and thymidine kinase
were involved in 5-fluorouracil (5-FU) toxicity and decreasing
in these enzymes was related to enhanced 5-FU cytotoxicity.
Carnesecchi et al. (2002a, b) also reported that geraniol can
lower the resistance of cancer cells to 5-FU and increase the
survival time of nude mice grafted with the human colorectal
tumor cells TC118 by increasing cell membrane permeability
which leaded to enhanced uptake of 5-FU by colon cancer cells
and causing a significant change in the resting potential and
cell membrane polarization and further may trigger modifica-
tions of membrane bound protein activity and alterations in
intracellular signaling pathways.
3.6. Anti-inflammatory activities
Ji et al. (2002) investigated geraniol's immunosuppressive
properties by using in vitro lymphocyte proliferation assays and
in vivo rat cardiac allograft transplant model. The results
revealed that geraniol can prevent acute allograft rejection. In
2003, Abe and his co-workers assessed the anti-inflammatory
activity of some essential oils on neutrophil activation by
measuring tumor necrosis factor-alpha (TNF-α)-induced ad-
herence reaction of human peripheral neutrophils in vitro. They
found that lemongrass, geranium, spearmint oils and their major
constituent terpenoids (citral, geraniol, citronellol and carvone)
clearly suppressed TNF-α-induced neutrophil adherence at
0.0125% concentration.
3.7. Other effects
Geraniol enhanced the anti-herpetic activity of antisense
phosphorothioate oligonucleotide (SON) with less cytotoxicity
in a sequence specific manner (Shoji et al., 1998). At high
concentration, geraniol appeared to have the potential to interact
with estrogen receptors by using recombinant yeast cells
expressing the human estrogen receptor (Howes et al., 2002).
Human CYP2B6 had been regarded as a minor hepatic drug-
metabolizing enzyme, and it was important in the metabolism
of drugs such as bupropion, cyclophosphamide, efavirenz,
sibutramine, and tamoxifen. Geraniol showed potent inhibition
of human CYP2B6 activity, with Ki values of 6.7 µM, which
was higher than the Ki (1.8 μM) of the well-known CYP2B6-
selective inhibitor thio-TEPA (Seo et al., 2008).
Azarmi et al. (2009) investigated the vascular effect of
geraniol by using isolated rat aorta. Geraniol in a dose de-
pendent manner reduced the contractile response to noradren-alin and relaxed of KCl induced active tone in rat aorta.
Relaxant effects of geraniol on the KCl induced contraction was
not modified by the NO synthase inhibitor N-nitro-L-arginine
methyl ester, methylene blue and indomethacin.
3.8. Absorption and transdermal enhancement effects of
geraniol and possible mechanism of action
The percutaneous absorption of geraniol from an oil-in-water
emulsion was studied by Doan et al. (2010). In vivo absorption
of geraniol 24 h after dermal application was 15.1±1.8% of
the applied dose. In vitro absorption of geraniol over 24 h was
45.9±3.2% of the applied dose in receptor fluid by using flow-
through diffusion cells (0.64 cm2). The difference between in
vivo and in vitro dermal absorption values for geraniol may be
due to the rapid evaporation of geraniol from the skin.
Transdermal drug delivery systems represent a novel and
beneficial therapeutic approach to the delivery of pharmaceu-
ticals. Terpenes have been used as penetration enhancers for
improved transdermal drug delivery (Aqil et al., 2007),
because they are reported to have good toxicological profiles,
high percutaneous enhancement abilities, and negligible
cutaneous irritancy at low concentration (1–5%) (Nokhodchi
et al., 2007). The acyclic monoterpene geraniol has also been
investigated as a percutaneous enhancer. Eleven monoterpenes
were investigated for their effect on percutaneous absorption of
three different model drugs with varying lipophilicities.
Geraniol gave a 16-fold increase in the permeation of caffeine
(Godwin and Michniak, 1999). Arellano et al. (1996) studied
the effect of 1% concentration of several terpenes in a carbopol
gel formulation containing propylene glycol on the excised
abdominal rat skin penetration of diclofenac sodium. The most
effective terpene was geraniol. Another study revealed that
addition of tetrahydrogeraniol in a gel containing 5-fluorouracil
markedly enhanced the 5-fluorouracil permeability. The maxi-
mum flux was obtained at a concentration of 8% tetrahydroger-
aniol (Hanif, 1998). In 2009, Kigasawa et al. examined in vivo
availability and safety of ion-exchange iontophoresis combined
with geraniol in the transdermal delivery of anionic diclofenac to
rat dorsal skin. The results revealed that geraniol combined with
iontophoresis increased the plasma concentration of diclofenac
sodium over 20-fold, and suppression of inflammation was
achieved. The enhancing effect of geraniol was attributed to
increased penetration of the drug into the stratum corneum as well
as enhanced transport across the anion-exchange membrane.
Recently, geraniol was found to increase permeation flux of the
antimicrobial agent, silver sulphadiazine, through third-degree
burn eschar with enhancement ratio of 5.5. The main mechanism
of geraniol increasing permeation of silver sulphadiazine was
ascribed to increased partitioning of this drug into the eschar
(Moghimi et al., 2009).
4. Toxicity and allergenicity
Toxicity of geraniol has been investigated in various
organisms. Rat studies have shown that neither 10000 ppm
geraniol in the diet fed for 16 weeks nor 1000 ppm in the diet
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1967). In clinical sensitization testing, 6% geraniol in
petrolatum was tested in 25 volunteers and produced no pos-
itive reactions (Greif, 1967). No mutagenic effects were ob-
served in an Ames test conducted on S. typhimurium with
0.5 mg geraniol in DMSO with and without S9 activation
(Ishidate et al., 1984).
Geraniol is not an electrophile and should consequently not
show any sensitizing capacity, but there are some reports of
allergic contact dermatitis resulting from sensitivity to geraniol
(Cardullo et al., 1989). In addition, geraniol is listed on the
European Union's 26 fragrance allergens that must be identified
on cosmetic and detergent product labels (Buckley, 2007).
Contact sensitization is caused by low molecular weight com-
pounds which penetrate the skin and bind to proteins. Hagvall
et al. (2007, 2008) reported that geraniol had the potential to
autoxidize on air exposure or by CYP-mediated metabolic
activation in the skin, and formed highly allergenic compounds.
The autoxidation of geraniol followed two paths, originating
from allylic hydrogen abstraction near the two double bonds.
Hydrogen peroxide was primarily formed together with
aldehydes geranial and neral from a hydroxyhydroperoxide,
and small amounts of a hydroperoxide was formed. The hy-
droperoxide formed was believed to be the major contributor to
allergenic activity, together with the aldehydes geranial and
neral (Hagvall et al., 2007). Geraniol could also be metabol-
ically activated to geranial, neral, 2,3-epoxygeraniol, 6,7-
epoxygeraniol and 6,7-epoxygeranial by a skin-like CYP
cocktail consisting of cutaneous CYP isoenzymes. Geranial,
neral and 6,7-epoxygeraniol were shown to be moderate
sensitizers, and 6,7-epoxygeranial a strong sensitizer (Hagvall
et al., 2008). In 2008, Lapczynski et al. comprehensively
summarized safety data relevant to the risk assessment of the
use of geraniol. They listed studies on oral, dermal, intramus-
cular, subcutaneous, inhalation acute toxicity; skin irritation and
sensitization; mucous membrane (eye) irritation of geraniol.
The scientific evaluation focused on dermal exposure because
skin was considered to be the primary exposure route for this
fragrance material. Phototoxicity and photoallergy, repeated
dose toxicity, mutagenicity and genotoxicity of geraniol were
also described.
5. Conclusions
Geraniol is abundant and occurs in a large number of plants.
This molecule is widely used as a fragrance chemical in both
cosmetic and household products. Several studies have
confirmed the pharmacological properties of this acyclic
monoterpene alcohol. Conclusive research has shown geraniol
to be an effective plant-based mosquito repellent, insecticide for
controlling pests with low mammalian toxicity and biodegrad-
ability. Geraniol is employed as natural enhancer to improve the
skin penetration of 5-fluorouracil, diclofenac sodium and silver
sulphadiazine. The good chemopreventive activity of geraniol
may present a new class of cancer therapeutic agent and renders
a great opportunity for further investigation. The several
biological properties of geraniol including antimicrobial, anti-oxidant and anti-inflammatory activities, together with negligi-
ble toxicity, warrant further studies to explore the feasibly of
formulating geraniol-containing consumer products with health
promoting properties.
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